Attached files
| file | filename |
|---|---|
| EX-99.2 - EXHIBIT 99.2 - Predictive Oncology Inc. | exh_992.htm |
| EX-99.1 - EXHIBIT 99.1 - Predictive Oncology Inc. | exh_991.htm |
| 8-K/A - FORM 8-K/A - Predictive Oncology Inc. | f8ka_012819.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-169556, No. 333-175565, No. 333-186464, No. 333-188510, No. 333-198378, No. 333-213742 and No. 333-216711) and on Form S-3 (No. 333-228908 and No. 333-213766) of Precision Therapeutics, Inc. of our audit report dated January 22, 2019, relating to the consolidated financial statements of Helomics Holding Corporation and Subsidiaries as of and for the nine months ended September 30, 2018, which appears in Exhibit 99.1 to this Form 8-K/A.
Schneider Downs & Co., Inc.
/s/ Schneider Downs & Co., Inc.
Pittsburgh, Pennsylvania
January 28, 2019